DK464686A - Praeparat med kontrolleret afgivelse af det aktive stof - Google Patents

Praeparat med kontrolleret afgivelse af det aktive stof Download PDF

Info

Publication number
DK464686A
DK464686A DK464686A DK464686A DK464686A DK 464686 A DK464686 A DK 464686A DK 464686 A DK464686 A DK 464686A DK 464686 A DK464686 A DK 464686A DK 464686 A DK464686 A DK 464686A
Authority
DK
Denmark
Prior art keywords
active substance
controlled delivery
prepared controlled
prepared
delivery
Prior art date
Application number
DK464686A
Other languages
English (en)
Other versions
DK170016B1 (da
DK464686D0 (da
Inventor
Othmar Zueger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK464686D0 publication Critical patent/DK464686D0/da
Publication of DK464686A publication Critical patent/DK464686A/da
Application granted granted Critical
Publication of DK170016B1 publication Critical patent/DK170016B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK464686A 1985-10-01 1986-09-29 Præparat med kontrolleret afgivelse af det aktive stof DK170016B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB8524135 1985-10-01
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB8524653 1985-10-07
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB8531419 1985-12-20
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB8603097 1986-02-07
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions
GB8605037 1986-02-28

Publications (3)

Publication Number Publication Date
DK464686D0 DK464686D0 (da) 1986-09-29
DK464686A true DK464686A (da) 1987-04-02
DK170016B1 DK170016B1 (da) 1995-05-01

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464686A DK170016B1 (da) 1985-10-01 1986-09-29 Præparat med kontrolleret afgivelse af det aktive stof

Country Status (20)

Country Link
KR (1) KR920008817B1 (da)
AT (1) AT402257B (da)
BE (1) BE905516A (da)
CA (1) CA1298784C (da)
CH (1) CH669524A5 (da)
DE (1) DE3632201C2 (da)
DK (1) DK170016B1 (da)
ES (1) ES2002508A6 (da)
FR (1) FR2589732B1 (da)
GR (1) GR862457B (da)
HK (1) HK392A (da)
HU (1) HU197201B (da)
IE (1) IE59589B1 (da)
IL (1) IL80182A (da)
LU (1) LU86615A1 (da)
NL (1) NL194822C (da)
NZ (1) NZ217732A (da)
PT (1) PT83456B (da)
SE (1) SE503222C2 (da)
SG (1) SG103391G (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6855729B2 (en) * 2001-02-20 2005-02-15 Timothy G. Dinan Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
SE8604112D0 (sv) 1986-09-29
AT402257B (de) 1997-03-25
HK392A (en) 1992-01-10
NL194822B (nl) 2002-12-02
SG103391G (en) 1992-01-17
IE59589B1 (en) 1994-03-09
PT83456B (pt) 1989-05-12
IE862565L (en) 1987-04-01
NZ217732A (en) 1990-07-26
CA1298784C (en) 1992-04-14
ATA260486A (de) 1996-08-15
NL8602370A (nl) 1987-05-04
HUT44701A (en) 1988-04-28
NL194822C (nl) 2003-04-03
DK170016B1 (da) 1995-05-01
IL80182A (en) 1991-01-31
DE3632201A1 (de) 1987-04-02
IL80182A0 (en) 1986-12-31
HU197201B (en) 1989-03-28
KR920008817B1 (ko) 1992-10-09
FR2589732B1 (fr) 1989-07-13
SE8604112L (sv) 1987-04-02
PT83456A (en) 1986-10-01
BE905516A (fr) 1987-03-30
SE503222C2 (sv) 1996-04-22
CH669524A5 (da) 1989-03-31
DE3632201C2 (de) 1997-05-07
FR2589732A1 (fr) 1987-05-15
KR870003777A (ko) 1987-05-04
DK464686D0 (da) 1986-09-29
GR862457B (en) 1987-01-29
ES2002508A6 (es) 1988-08-16
LU86615A1 (fr) 1987-04-02

Similar Documents

Publication Publication Date Title
DK324385D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
FI865231L (fi) Dioler med stor molekylvikt foer foerbaettrade vaetskeformiga rengoeringsmedel.
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK158770C (da) Anvendelse af paroxetin til fremstilling af medikament mod fedme
NO862956L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
DK354385A (da) Liposom-kompatibelt overfladeaktivt stof
DK272383A (da) Farmaceutisk blandingspraeparat med kontrolleret frigivelse af aktivt stof indbefattet maskering af daarlig smag og foroegelse af det aktive stofs stabilitet
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
DK106685D0 (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK396286A (da) Injicerbar formulering med forsinket frigivelse af den aktive bestanddel
DK524489D0 (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
DK516286A (da) Fremgangsmaade til fremstilling af oxazolderivater
DK268783D0 (da) Insecticide sammensaetninger med hoej koncentration af aktivt stof
DK115291D0 (da) Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater
DK586586A (da) Biologisk aktive amidderivater
DK522986A (da) Fremgangsmaade til indgift af ethanolaminderivater til husdyr
DK464686A (da) Praeparat med kontrolleret afgivelse af det aktive stof
DK163980A (da) Fremgangsmaade til fremstilling af et biologisk aktivt stof 41.200rp med immunstimulerende virkning
DK162631C (da) Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen
DK206985A (da) Transdermal doseringsform med forbedret gennemtraengning af det aktive stof
DK258886D0 (da) Fremgangsmaade til fremstilling af alkyloxiraner
MX163537B (es) Composicion insecticida
DK509986A (da) Fremgangsmaade til fremstilling af aryl-cyanamider

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired